2005•The LancetRequires access

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk, Stefan Zeuzem, Ulus Salih Akarca, Yılmaz Çakaloğlu, Christopher Simon, Thomas M. K. So, Guido Gerken, Robert Auke de Man, Hubert G.M. Niesters, Pieter E. Zondervan, Bettina E. Hansen, Solko Walle Schalm

Open publisher page 1,167 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1167 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Lamivudine, Internal medicine, Pegylated interferon, HBeAg, Gastroenterology, Combination therapy, Placebo